Relative contribution of VKORC1, CYP2C9, and INR response to warfarin stable dose

被引：15
|
作者：
Suarez-Kurtz, Guilherme [1 ]
Perini, Jamila A. [1 ]
Silva-Assuncao, Edimilson [1 ]
Struchiner, Claudio J. [1 ]
机构：
[1] Inst Nacl Canc, Div Farmacol, BR-21230050 Rio De Janeiro, Brazil
来源：
BLOOD | 2009年 / 113卷 / 17期
关键词：
POLYMORPHISMS; REQUIREMENTS;
D O I：
10.1182/blood-2009-01-200600
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4125 / 4126
页数：2
相关论文
共 50 条
  • [41] Effects of CYP2C9 and VKORC1 on INR variations and dose requirements during initial phase of anticoagulant therapy
    Spreafico, Marta
    Lodigiani, Corrado
    Leeuwen, Yvan
    Pizzotti, Denise
    Rota, Lidia L.
    Rosendaal, F. R.
    Mannucci, Pier M.
    Peyvandi, Flora
    PHARMACOGENOMICS, 2008, 9 (09) : 1237 - 1250
  • [42] Association between polymorphisms of the VKORC1 and CYP2C9 genes and warfarin maintenance dose in Peruvian patients
    Oscanoa, Teodoro J.
    Guevara-Fujita, Maria L.
    Fujita, Ricardo M.
    Munoz-Paredes, Maria Y.
    Acosta, Oscar
    Romero-Ortuno, Roman
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (03) : 769 - 775
  • [43] The effects of CYP2C9 and VKORC1 gene polymorphisms on warfarin maintenance dose in Turkish cardiac patients
    Akdeniz, Cansu Selcan
    Cevik, Mehtap
    Canbolat, Ismail Polat
    Yurdakul, Selen
    Cagatay, Penbe
    Ciftci, Cavlan
    Karaalp, Atila
    Susleyici, Belgin
    FUTURE CARDIOLOGY, 2020, 16 (06) : 645 - 654
  • [44] Impact of CYP2C9, VKORC1, ApoE and ABCB1 polymorphisms on stable warfarin dose requirements in elderly Chinese patients
    Li, Wenyan
    Zhao, Ping
    Chen, Liwen
    Lai, Xiaoyin
    Shi, Guohua
    Li, Longxuan
    Dong, Jing
    PHARMACOGENOMICS, 2020, 21 (02) : 101 - 110
  • [45] The influence of VKORC1 and CYP2C9 mutations on warfarin response after total hip and knee arthroplasty
    Wise, Eric S.
    Gadomski, Stephen P., II
    McMaster, William G., Jr.
    Wilson, Robert J.
    Nelms, Justin K.
    Hocking, Kyle M.
    Brophy, Colleen M.
    JOURNAL OF ORTHOPAEDICS, 2015, 12 : S145 - S151
  • [46] Influence of CYP2C9 and VKORC1 on Patient Response to Warfarin: A Systematic Review and Meta-Analysis
    Jorgensen, Andrea L.
    FitzGerald, Richard J.
    Oyee, James
    Pirmohamed, Munir
    Williamson, Paula R.
    PLOS ONE, 2012, 7 (08):
  • [47] Comparison of Three Commercial CYP2C9/VKORC1 Genotyping Assays for Warfarin Sensitivity
    Maurice, C. B.
    Barua, P. K.
    Simses, D.
    Smith, P.
    Howe, J. G.
    Stack, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 566 - 566
  • [48] Influence of CYP2C9 and VKORC1 Polymorphisms on Warfarin and Acenocoumarol in a Sample of Lebanese People
    Esmerian, Maria O.
    Mitri, Zahi
    Habbal, Mohammad-Zuheir
    Geryess, Eddy
    Zaatari, Ghazi
    Alam, Samir
    Skouri, Hadi N.
    Mahfouz, Rami A.
    Taher, Ali
    Zgheib, Nathalie K.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (10): : 1418 - 1428
  • [49] VKORC1 and CYP2C9 Genotypes are Predictors of Warfarin-Related Outcomes in Children
    Shaw, Kaitlyn
    Amstutz, Ursula
    Hildebrand, Claudette
    Rassekh, S. Rod
    Hosking, Martin
    Neville, Kathleen
    Leeder, J. Steven
    Hayden, Michael R.
    Ross, Colin J.
    Carleton, Bruce C.
    PEDIATRIC BLOOD & CANCER, 2014, 61 (06) : 1055 - 1062
  • [50] Comparison of assay systems for warfarin-related CYP2C9 and VKORC1 genotyping
    Maurice, Carleta B.
    Barua, Pankaj K.
    Simses, Diane
    Smith, Penny
    Howe, John G.
    Stack, Gary
    CLINICA CHIMICA ACTA, 2010, 411 (13-14) : 947 - 954
12345